相关实验视频
Updated: Jul 27, 2025

06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
6.7K
胃衰竭:神话,误解和管理方法
David J Cangemi1, Brian E Lacy1
1Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Clinical and experimental gastroenterology
|June 12, 2023
概括
本综述澄清了关于胃 (GP) 的常见误解,这种情况会导致胃排空延迟. 消除这些误解是改善患有这种具有挑战性的胃肠道疾病的患者诊断和治疗的关键.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 胃衰竭 (GP) 呈现为恶心,吐,腹痛,早期和膨胀,与延迟胃排空有关.
- 一般医生很难治疗,严重影响患者的生活质量和医疗费用.
研究的目的:
- 识别和解决围绕胃衰竭的普遍神话和误解.
- 为了使GP的理解与病因学,病理生理学,诊断和治疗方面的最新研究发现保持一致.
主要方法:
- 文献综述侧重于最近的胃衰竭研究.
- 分析当前的理解与GP管理中的既定神话.
主要成果:
- 确定了许多关于胃衰竭的原因和机制的持久神话.
- 强调需要基于证据的方法来应对GP护理中的错误信息.
结论:
- 消除关于胃衰竭的误解对于推进临床管理至关重要.
- 准确了解GP病理生理学和病因学将导致更好的治疗策略.
相关概念视频
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
209
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
209
Gastrointestinal Motility Disorders
461
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
461
Peptic Ulcer Disease V: Surgical Management and Nursing Care
349
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
349
Gastroesophageal Reflux Disease II: Clinical Features and Management
120
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
120
Gastritis III: Clinical Manifestations and Management
342
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
342
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
